Denis Chem Lab

Denis Chem Lab P/B

The P/B (Price-to-Book Ratio) of Denis Chem Lab (537536.BO) as of Oct 21, 2026 is 1.17. In the previous year, P/B (Price-to-Book Ratio) was 1.26 — a change of -7.06% (lower).

P/B

1.17

YoY

-7.06%

Last updated:

P/B (Price-to-Book Ratio) of Denis Chem Lab is 2025 1.17 . P/B (Price-to-Book Ratio) of Denis Chem Lab was 2024 1.26 . It decreases by -7.06% lower compared to the previous year.

The Denis Chem Lab P/B history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/B
Date
P/B
Jan 1, 2018
1.90 INR
Jan 1, 2019
1.81 INR
Jan 1, 2020
1.74 INR
Jan 1, 2021
1.61 INR
Jan 1, 2022
1.48 INR
Jan 1, 2023
1.33 INR
Jan 1, 2024
1.26 INR
Jan 1, 2025
1.17 INR
The Denis Chem Lab P/B history
YEARP/BYoY
1.17-7.06%
1.26-5.57%
1.33-10.08%
1.48-8.04%
1.61-7.44%
1.74-3.93%
1.81-4.45%
1.90-11.55%
2.14-40.21%
3.59-44.84%
6.50-42.56%
11.32—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Denis Chem Lab Stock analysis

What does Denis Chem Lab do? Denis Chem Lab Ltd. generates revenue through the manufacture and sale of transfusion solutions in bottles, including sterile intravenous injectables for human and veterinary use. The company offers a range of products such as carbohydrate solutions, sodium chloride solutions, potassium chloride solutions, and plasma volume expanders under its own brands. It also produces sterile intravenous injectables in volumes from 100 milliliters to 10 liters for direct sales to customers. Additionally, the firm manufactures contract products for multinational pharmaceutical companies, leveraging its facility for third-party production. The company's primary customers include healthcare providers and veterinary institutions that require sterile intravenous solutions. Its product portfolio targets both human and veterinary markets, with offerings like antibiotic solutions and dialysis solutions catering to specific medical needs. The firm's contract manufacturing services provide an additional revenue stream by supplying multinational pharmaceutical companies with custom-produced sterile injectables. Denis Chem Lab Ltd. focuses on manufacturing and selling its own branded products, such as carbohydrate in sodium chloride solutions and multi electrolyte solutions, while also engaging in contract manufacturing for multinational pharmaceutical companies. The company's production capabilities span from small-volume solutions to large 10-liter bottles, ensuring versatility in meeting diverse customer demands across healthcare and veterinary sectors. Denis Chem Lab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Denis Chem Lab stock

P/B (Price-to-Book Ratio) of Denis Chem Lab is 1.17 in 2025.

P/B (Price-to-Book Ratio) of Denis Chem Lab changed from 1.26 to 1.17, representing a -7.06% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Denis Chem Lab since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Denis Chem Lab with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Denis Chem Lab

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Denis Chem Lab